Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)

NCT01253317 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Rett Syndrome

Interventions

DRUG: rhIGF-1

Sponsor

Boston Children's Hospital

Collaborators

[object Object]
[object Object]